Characteristic | Value |
---|---|
n | 1033 |
Age at initial usage (median, IQR) | 13.0 (9.2–15.8) |
Years of exposure (median, IQR) | 1.0 (0.17–2.4) |
Female | 592 (57%) |
Race | |
Caucasian | 771 (75%) |
African-American | 251 (24%) |
Other / unknown | 11 (1.1%) |
Number of TNF inhibitors used | |
1 | 768 (74%) |
2 | 227 (22%) |
3 | 37 (3.6%) |
4 | 1 (0.1%) |
Diagnosis | |
JIAa | 544 |
IBDa | 265 |
IBD with JIAa | 69 |
Vasculitis | 33 |
Uveitis | 31 |
Psoriasis | 29 |
Sarcoidosis | 17 |
Mixed connective tissue disease / SLE | 13 |
Sjogren Syndrome | 7 |
Recurrent fever syndrome | 6 |
Behcet Syndrome | 5 |
Hidradenitis | 3 |
Juvenile dermatomyositis | 3 |
Non-infectious osteomyelitis | 3 |
Sensorineural hearing loss | 2 |
Otherb | 3 |
Cases of Tuberculosis | 1 |